Massachusetts Financial Services
AVIR icon

Massachusetts Financial Services’s Atea Pharmaceuticals AVIR Stock Holding History

Massachusetts Financial Services’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-51,137
Closed -$291K – 847
2022
Q3 		$291K Sell
51,137
-465
-0.9% -$3.56K ﹤0.01% 835
2022
Q2 		$366K Buy
51,602
+259
+0.5% +$1.77K ﹤0.01% 823
2022
Q1 		$371K Buy
51,343
+527
+1% +$3.58K ﹤0.01% 839
2021
Q4 		$454K Buy
+50,816
New +$792K ﹤0.01% 859

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Massachusetts Financial Services's AVIR Position: Q4 2022 in Review

Massachusetts Financial Services sold out of Atea Pharmaceuticals (AVIR) in Q4 2022, closing a stake of 51,137 shares — an estimated $291K sold.

Massachusetts Financial Services first reported a position in AVIR in Q4 2021 and held it in 4 quarters. The position peaked at $454K in Q4 2021. 131 funds tracked by Wall St. Rank hold AVIR as of Q4 2022.

  • Massachusetts Financial Services reported no remaining Atea Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 51,137 Atea Pharmaceuticals shares in Q4 2022, an estimated $291K.
  • Massachusetts Financial Services first reported a position in Atea Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Massachusetts Financial Services's Atea Pharmaceuticals position peaked at $454K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q4 2022.

Based on Massachusetts Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.